Patents by Inventor Eva Schmidt

Eva Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040186170
    Abstract: The present invention is a piperazinylalkylbenzofuran derivative of the formula 1
    Type: Application
    Filed: December 15, 2003
    Publication date: September 23, 2004
    Applicant: EGIS GYOGYSZERGYAR
    Inventors: Katalin Ivanicsne Megyeri, Aniko Miklosne Kovacs, Ildiko Nagyne Gyonos, Bela Agai, Jozsef Reiter, Gyula Simig, Endre Rivo, Zoltan Tamas Nagy, Levente Ondi, Szabolcs Keriesz, Gabor Szenasi, Eva Schmidt, Katalin Pallagi, Istvan Gacsalyi, Istvan Gyeriyan, Tamas Szabados, Gyorgy Levay, Andras Egyed
  • Publication number: 20040171619
    Abstract: The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel compounds possess neuroleptic effect and can be used, primarily, for the treatment of schizophrenia. In formula I, R stands for a hydrogen atom or a C1-4, alkyl group, X and Y represent, independently, a hydrogen atom, a halogen atom or a group of the formula II, with the proviso that one of X and Y means always a group of the formula II, and then the other one stands for a hydrogen atom or a halogen atom, wherein in formula II n has a value of 1 or 2.
    Type: Application
    Filed: April 23, 2004
    Publication date: September 2, 2004
    Inventors: Jozsef Barkoczy, Peter Kotay Nagy, Gyula Simig, Gyorgy Levay, Istvan Gacsalyi, Andras Egyed, Judit Raczne Bajnogel, Katalin Pallagi, Eva Schmidt, Gabor Szenasi, Aniko Miklosne Kovacs, Janos Wellmann
  • Patent number: 6191152
    Abstract: The invention refers to novel 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives of formula (I) having an influence on the heart and the central nervous system, furthermore pharmaceutical compositions containing the above derivatives, and a process for the preparations of the novel compounds.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: February 20, 2001
    Assignee: EGIS Gyógyszergyar Rt.
    Inventors: József Reiter, József Barkóczy, Gábor Berecz, Gyula Simig, András Egyed, Katalin Ivanicsné Megyeri, Sándor Drabant, Szabolcs Kertész, Anikó Miklósné Kovács, Ildikó Nagyné Gyönös, Mária Szécseyné Hegedüs, Gábor Szénási, János Wellmann, Katalin Pallagi, Éva Schmidt, Károly Tihanyi, Péter Trinka, Margit Csörgö
  • Patent number: 6130215
    Abstract: The invention refers to novel piperazinylalkylthiopyrimidine derivatives of formula (I) being suitable for the treatment of diseases due to pathological alterations of the central nervous system, pharmaceutical compositions containing the above derivatives, and a process for the preparation of the novel compounds.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: October 10, 2000
    Assignee: Egis Gyoyszergyar RT
    Inventors: Ivan Jakoczi, Daniel Bozsing, Ildiko Ratz nee Simonek, Istvan Gacsalyi, Gabor Szenasi, Eva Schmidt, Aniko Miklos nee Kovacs, Andras Bilkei-Gorzo, Gabor Blasko, Istvan Gyertyan, Gabor Nemeth, Gyula Simig, Karoly Tihanyi, Andras Egyed
  • Patent number: 6093747
    Abstract: The new compound of Formula (I) and salts thereof possess valuable anxiolytic properties.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: July 25, 2000
    Assignee: Egis Gyogyszergyar RT.
    Inventors: Istvan Gacsalyi, Imre Klebovich, Zoltan Budai, Gyula Lukacs, Erzsebet Kaufmanne Bojti, Eva Schmidt, Istvan Gyertyan, Andras Bilkei Gorzo, Gabor Blasko, Miklos Abermann, Katalin Baloghne Nemes, Gyula Grezal, Andras Egyed
  • Patent number: 5486528
    Abstract: Novel basic ether of general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen, halogen or C.sub.1-4 alkoxy, or together they represent a 3,4-methylenedioxy group,R stands for C.sub.1-8 alkyl,R.sup.3 represents hydrogen, C.sub.1-4 alkyl or hydroxy,A is a valency bond or methylene group,R.sup.4 and R.sup.5 are independently hydrogen, C.sub.1-12 alkyl or C.sub.1-12 alkenyl, orR.sup.4 and R.sup.5 form together with the adjacent nitrogen atom 1-pyrrolidinyl, 1-piperidinyl, morpholino or 1-piperazinyl groups, stereo and optically active isomers and their possible mixtures, acid-addition salts and quaternary ammonium derivatives thereof. The basic ethers have antiulceric and anxiolytic activities.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: January 23, 1996
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: Judit Bajnogel, Gabor Blasko, Zoltan Budai, Eva Schmidt, Andras Egyed, Marton Fekete, Istvan Gacsalyi, Istvan Gyertyan, Tibor Mezei, Kalara Reiter nee Esses, Gyula Simig, Katalin Szemeredi, Enik Szirt nee Kiszelly
  • Patent number: 5043224
    Abstract: A process for enhanced thermal oxidation and nitridation of silicon by introduction of fluorine into the oxidation and nitridation ambients.
    Type: Grant
    Filed: April 5, 1990
    Date of Patent: August 27, 1991
    Assignee: Lehigh University
    Inventors: Ralph J. Jaccodine, Paul Schmidt, deceased, Eva Schmidt, executrix